Mechanism Synergy Semaglutide: GLP-1 receptor agonist enhances insulin secretion, reduces appetite, delays gastric emptying
While higher doses (particularly 54 mg) showed some increase in gastrointestinal-related events, these remained mild to moderate in severity and did not result in treatment discontinuation
Ethics declarations Ethics approval and consent to participate Approved by Ethics Committee, School of Medicine, University of Zagreb, 04-1121-2006 for experiments with rats
Smith Jan 12, 2026 Daddy Yankee: A Higher Note Nov 20, 2025 Gut Check: The Foods We Eat Nov 19, 2025 All Access With Linsey Davis: Stevie Van Zandt Nov 18, 2025 All Access with Linsey Davis: Andrew Cuomo Oct 30, 2025 All Access With Linsey Davis: Zohran Mamdani Oct 27, 2025 Springsteen: Deliver Me from Nowhere - A Conversation with the Cast Oct 21, 2025 All Access With Linsey Davis: Jeremy Allen White Oct 20, 2025 The Children of Gaza Oct 11, 2025 Glen Powell and Eli Manning: ABC News Live Prime with Linsey Davis Oct 06, 2025 The Playlist Presents: Dale Play